Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Experts are anticipating strong growth driven by the strong demand of Lilly's blockbuster treatments, particularly its insulin portfolio. However, there are also concerns about potential headwinds fro